ICAM-1 and platelet counts as biomarkers for severity and outcomes in acute ischemic stroke: a cross-sectional study
Keywords:
Acute ischemic stroke, ICAM-1, platelet counts, stroke biomarkers, stroke severity, clinical outcomes in strokeAbstract
Background and aim: Stroke is a major global cause of death and disability. Timely intervention is essential to reducing both mortality and disability in ischemic stroke patients. Biomarkers such as Intercellular Adhesion Molecule-1 (ICAM-1), which is involved in inflammation and tissue damage, and platelet count (PC), which reflects platelet activity, are hypothesized to aid in predicting stroke outcomes. The objective of this study was to evaluate the relationship between serum ICAM-1 levels, platelet count, stroke severity, and clinical outcomes in patients with acute ischemic stroke.
Methods: A cross-sectional study was conducted in 63 patients with ischemic stroke. Serum ICAM-1 levels were measured via ELISA, platelet count through standard blood tests, and stroke severity using the National Institutes of Health Stroke Scale (NIHSS). Clinical outcomes were assessed with the modified Rankin Scale (mRS).
Results: The study found that stroke patients had higher mean levels of ICAM-1 compared to control participants, but the difference was not statistically significant (p = 0.888). Similarly, the mean platelet count in stroke patients was lower than in control participants, but the difference was also not significant (p = 0.13). Additionally, there was no significant association or correlation between ICAM-1 levels and NIHSS scores or mRS scores, as well as between platelet count levels and NIHSS scores or mRS scores.
Conclusions: Based on the results of this study, ICAM-1 levels and platelet counts may not serve as reliable biomarkers for assessing the severity of acute ischemic stroke or predicting clinical outcomes.
References
American Heart Association/American Stroke Association. An Updated Definition of Stroke for the 21st Century. Stroke. 2013;44:2064-2089.
Hui C, Tadi P, Khan Suheb MZ, Patti L. Ischemic Stroke. In: StatPearls [Internet] Treasure Island (FL). Published online 2018.
Chugh C. Acute ischemic stroke: Management approach. Indian Journal of Critical Care Medicine. 2019;23:S140-S146. doi:10.5005/jp-journals-10071-23192
Venketasubramanian N, Yudiarto FL, Tugasworo D. Stroke Burden and Stroke Services in Indonesia. Cerebrovasc Dis Extra. 2022;12(1):53-57. doi:10.1159/000524161
World Health Organization. Stroke. Cerebrovascular accident. Published online 2023.
Huang Y, Wang Z, Huang ZX, Liu Z. Biomarkers and the outcomes of ischemic stroke. Front Mol Neurosci. 2023;16. doi:10.3389/fnmol.2023.1171101
Wang L, Chen Y, Feng D, Wang X. Serum ICAM-1 as a Predictor of Prognosis in Patients with Acute Ischemic Stroke. Biomed Res Int . Published online 2021.
Yang M, Pan Y, Li Z, et al. Platelet count predicts adverse clinical outcomes after ischemic stroke or TIA: Subgroup analysis of CNSR II. Front Neurol. 2019;10(APR). doi:10.3389/fneur.2019.00370
Broderick JP, Adeoye O, Elm J. Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials. Stroke. 2017;48(7):2007-2012. doi:10.1161/STROKEAHA.117.017866
Rowley HA. Using the National Institutes of Health Stroke Scale. In: Stroke. Vol 44. Lippincott Williams and Wilkins; 2017. doi:10.1161/STROKEAHA
Nimbvikar AA, Panchawagh S, Chavan AP, Ingole JR, Pargaonkar Y, Pai R. Modified rankin scale is a reliable tool for the rapid assessment of stroke severity and predicting disability outcomes. J Family Med Prim Care. 2024;13(3):1085-1090. doi:10.4103/jfmpc.jfmpc_1431_23
Ministry of Health of the Republic of Indonesia. Results of the Basic Health Research. Jakarta: Health Research and Development Agency, Ministry of Health of the Republic of Indonesia. Published online 2018.
Akbar M, Misbach J, Yasmar Alfa A, et al. Clinical features of transient ischemic attack or ischemic stroke patients at high recurrence risk in Indonesia. Neurol Asia. 2018;23:107-113.
Frey BM, Boutitie F, Cheng B, et al. Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial. Neurol Res Pract. 2020;2(1). doi:10.1186/s42466-020-00087-9
Wang J, Zhou D, Li JC, et al. Association of Soluble Intercellular Adhesion Molecule 1 with Neurological Deterioration of Ischemic Stroke: The Chongqing Stroke Study. Cerebrovasc Dis. 2006;21:67-73.
Supanc V, Biloglav Z, Kes VB, Demarin V. Role of cell adhesion molecules in acute ischemic stroke. Ann Saudi Med. 2011;31(4):365-370.
Rakhimbaeva GS, Abdurakhmonova KB kizi. ICAM-1 and CRP as biomarkers of 3-month outcome in acute ischaemic stroke. BMJ Neurol Open. 2023;5(2). doi:10.1136/bmjno-2023-000516
Kanazawa K, Miyamoto N, Hira K. Baseline platelet count may predict short-term functional outcome of cerebral infarction. BMC Neurol 22. 2022;314.
J Du, Q Wang, B He, et al. Association of mean platelet volume and platelet count with the development and prognosis of ischemic and hemorrhagic stroke. Int J Lab Hematol. 2016;38(3):233-239.
Salaudeen MA, Bello N, Danraka RN, Ammani ML. Understanding the Pathophysiology of Ischemic Stroke: The Basis of Current Therapies and Opportunity for New Ones. Biomolecules. 2024;14(3). doi:10.3390/biom14030305
Downloads
How to Cite
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
